Literature DB >> 6548009

Prevention of neonatal hyperbilirubinemia in rhesus monkeys by tin-protoporphyrin.

C E Cornelius, P A Rodgers.   

Abstract

Rhesus monkey infants were injected subcutaneously at birth with 12 to 100 mumol of tin-protoporphyrin IX, a competitive inhibitor of microsomal heme oxygenase. The elevated unconjugated serum bilirubin levels of the neonates receiving this metalloporphyrin rapidly declined to near adult levels by 24-30 h. Control neonates which received an injection of saline exhibited normal physiologic hyperbilirubinemias of from 3-6 mg/dl by 12-24 h as expected. These studies establish the effectiveness of tin-protoporphyrin IX in depressing bilirubin production and preventing physiologic hyperbilirubinemia in simian neonates. Two of six animals receiving the metalloporphyrin exhibited signs of toxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548009     DOI: 10.1203/00006450-198408000-00010

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

1.  Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.

Authors:  G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

2.  The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.

Authors:  A Kappas; C S Simionatto; G S Drummond; S Sassa; K E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 3.  Control of heme metabolism with synthetic metalloporphyrins.

Authors:  A Kappas; G S Drummond
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver.

Authors:  A Kappas; G S Drummond; M K Sardana
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

5.  Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.

Authors:  L Berglund; B Angelin; R Hultcrantz; K Einarsson; L Emtestam; G Drummond; A Kappas
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 6.  Metalloporphyrins in the management of neonatal hyperbilirubinemia.

Authors:  David K Stevenson; Ronald J Wong
Journal:  Semin Fetal Neonatal Med       Date:  2009-12-16       Impact factor: 3.926

7.  Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.

Authors:  C S Simionatto; K E Anderson; G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 8.  Management of neonatal hyperbilirubinaemia and prevention of kernicterus.

Authors:  F F Rubaltelli; P F Griffith
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

9.  Metalloporphyrins-Applications and clinical significance.

Authors:  R Chandra; M Tiwari; P Kaur; M Sharma; R Jain; S Dass
Journal:  Indian J Clin Biochem       Date:  2000-08

10.  Metalloporphyrins - an update.

Authors:  Stephanie Schulz; Ronald J Wong; Hendrik J Vreman; David K Stevenson
Journal:  Front Pharmacol       Date:  2012-04-26       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.